Silence Therapeutics plc's Zerlasiran has done well, but Eli Lilly's Muvalaplin is simply better. Read more about SLN stock ...
The company recently announced results from two Phase 3 trials of AXS-05 for agitation. ACCORD-2, hit its main goal, but ADVANCE-2 didn't.
AquaSculpt is a weight loss supplement based on an “odd ice water hack.” Taking one capsule of AquaSculpt daily with a glass ...